Wordt geladen...
Ranirestat for the Management of Diabetic Sensorimotor Polyneuropathy
OBJECTIVE: Aldose reductase inhibitors (ARIs) are potential disease modifiers for diabetes complications. We aimed to determine whether ranirestat, an ARI, could slow or reverse the course of diabetic sensorimotor polyneuropathy (DSP). RESEARCH DESIGN AND METHODS: A total of 549 patients with DSP we...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Diabetes Association
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2699746/ https://ncbi.nlm.nih.gov/pubmed/19366965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-2110 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|